HalfLifeDBEvidence before certainty.

Muscimol evidence profile

The cited paper uses a muscimol radioreceptor assay in a rabbit study of another compound.

Category: psychedelic · Updated: August 7, 2026

Sources and model notes are maintained by . This page is educational, not clinical guidance. Corrections: admin@halflifedb.co.

Model statusNo curve publishedCurrent sources do not support one defensible human input
Evidence boundarySource note onlyNo animal, forensic, mixture, or proxy value is presented as a human half-life
Model scopeNot modeledThe profile explains what the available records can and cannot establish
References2Linked studies, labels, reviews, or identity records described below

Muscimol: evidence and interpretation notes

Why HalfLifeDB does not plot Muscimol

The cited paper uses a muscimol radioreceptor assay in a rabbit study of another compound. It does not measure human muscimol elimination, so it cannot support the former curve.

What each source contributes

  • PubChem: Muscimol. This identity record confirms names and compound identity and does not supply a human half-life.
  • Acid metabolite of progabide pharmacokinetics following single administration in the rabbit with special references to HPLC and (3H) muscimol radioreceptor assay. This preclinical study documents species-specific disposition or assay work and is not translated into a typical human estimate.

For Muscimol, the decision to withhold a curve turns on the limits visible in Acid metabolite of progabide pharmacokinetics following single administration in the rabbit with special references to HPLC and (3H) muscimol radioreceptor assay. This preclinical study documents species-specific disposition or assay work, but it is not translated into a typical human estimate.

What evidence would change the page

Before Muscimol could move from an evidence note to a chart, a study would need serial human measurements of the parent compound after a defined route, enough sampling to characterize elimination, and a population narrow enough to label honestly. That is a different evidence package from Acid metabolite of progabide pharmacokinetics following single administration in the rabbit with special references to HPLC and (3H) muscimol radioreceptor assay.

InterpretationCategory context and evidence limits

psychedelic context

Psychedelic duration is shaped by pharmacodynamics as well as pharmacokinetics, so subjective effects may not track a simple elimination curve.

  • The curve does not predict psychological effects or functional safety.
  • Metabolites and downstream receptor activity are not separately modeled.
  • Published estimates may come from small or specialized study populations.
EvidenceSource trail and model decision

Sources and evidence context

A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.

1 PubMed0 PMC0 DailyMed1 PubChem
  1. Identity record PubChem Compound Summary: Muscimol.
    Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
  2. Research abstract PubMed: Acid metabolite of progabide pharmacokinetics following single administration in the rabbit with special references to HPLC and (3H) muscimol radioreceptor assay.
    Rabbit pharmacokinetic study involving a related assay context; included as indirect evidence because human data are limited.
BoundariesWhat this page cannot answer and where to continue

What this page does not answer

  • It does not estimate impairment, intoxication, or fitness to drive.
  • It does not predict urine, blood, saliva, or hair test results.
  • It does not model repeated exposure, tolerance, withdrawal, or interactions.
  • It does not replace clinician, pharmacist, toxicologist, or emergency guidance.

Continue with context

Read the medical disclaimer, methodology, and research standards before using the model for comparison.